Stock VRTX VERTEX PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
396.2 USD -0.32% Intraday chart for Vertex Pharmaceuticals Incorporated -0.93% -2.63%
04-26 Vertex Pharmaceuticals Gets European Commission Approval for Cystic Fibrosis Treatment for Infants MT
04-26 Vertex Pharmaceuticals Announces European Commission Approval for KALYDECO to Treat Infants with Cystic Fibrosis Ages 1 Month and Older CI

Official Publications

SEC Filing 10K CO
SEC Filing 13G CO
SEC Filing 13G CO
Slide show results CO
Annual results CO
SEC Filing 8K CO
SEC Filing 8K CO
SEC Filing 10Q-3 CO
Slide show Q3 CO
3rd quarter results CO
SEC Filing 8K CO
SEC Filing 10Q-2 CO
Slide show half-year results CO
1st-half-year results CO
SEC Filing 8K CO
SEC Filing 10Q-1 CO
Slide show Q1 CO
1st quarter results CO
SEC Filing 8K CO
SEC Filing 13G CO
SEC Filing 10K CO
SEC Filing 13G CO
Slide show results CO
Annual results CO
SEC Filing 8K CO
12
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. News Vertex Pharmaceuticals Incorporated
  5. Official Publications